132 related articles for article (PubMed ID: 31867433)
1. Clinical characteristics of CNS metastases from primary gynecologic cancers.
Zhang Y; Grant MS; Stepp WH; Clark LH
Gynecol Oncol Rep; 2019 Nov; 30():100518. PubMed ID: 31867433
[TBL] [Abstract][Full Text] [Related]
2. Incidence and survival of gynecologic cancer including cervical, uterine, ovarian, vaginal, vulvar cancer and gestational trophoblastic neoplasia in Korea, 1999-2019: Korea Central Cancer Registry.
Yun BS; Park EH; Ha J; Lee JY; Lee KH; Lee TS; Lee KJ; Kim YJ; Jung KW; Roh JW
Obstet Gynecol Sci; 2023 Nov; 66(6):545-561. PubMed ID: 37953552
[TBL] [Abstract][Full Text] [Related]
3. Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: A 12-year review at the Philippine General Hospital.
Cagayan MS; Lu-Lasala LR
J Reprod Med; 2006 Oct; 51(10):785-92. PubMed ID: 17086807
[TBL] [Abstract][Full Text] [Related]
4. Gamma Knife Surgery for Metastatic Brain Tumors from Gynecologic Cancer.
Matsunaga S; Shuto T; Sato M
World Neurosurg; 2016 May; 89():455-63. PubMed ID: 26844877
[TBL] [Abstract][Full Text] [Related]
5. Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes.
Gardner AB; Charo LM; Mann AK; Kapp DS; Eskander RN; Chan JK
Clin Exp Metastasis; 2020 Feb; 37(1):107-113. PubMed ID: 31758289
[TBL] [Abstract][Full Text] [Related]
6. Leptomeningeal metastases arising from gynecological cancers.
Yano H; Nagao S; Yamaguchi S
Int J Clin Oncol; 2020 Feb; 25(2):391-395. PubMed ID: 31586282
[TBL] [Abstract][Full Text] [Related]
7. Treatment of extremely high risk and resistant gestational trophoblastic neoplasia patients in King Chulalongkorn Memorial Hospital.
Oranratanaphan S; Lertkhachonsuk R
Asian Pac J Cancer Prev; 2014; 15(2):925-8. PubMed ID: 24568520
[TBL] [Abstract][Full Text] [Related]
8. Gestational trophoblastic disease metastatic to the central nervous system.
Evans AC; Soper JT; Clarke-Pearson DL; Berchuck A; Rodriguez GC; Hammond CB
Gynecol Oncol; 1995 Nov; 59(2):226-30. PubMed ID: 7590478
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity in gynecological tumors.
Sakamoto M; Toyoizumi T; Kikuchi Y; Okamoto A; Nakayama H; Aoki D; Yamamoto K; Hata H; Sugishita T; Tenjin Y
Oncol Rep; 2000; 7(5):1003-9. PubMed ID: 10948330
[TBL] [Abstract][Full Text] [Related]
10. Central nervous system metastases in patients with ovarian carcinoma. A report of 23 cases and a literature review.
Cormio G; Maneo A; Parma G; Pittelli MR; Miceli MD; Bonazzi C
Ann Oncol; 1995 Jul; 6(6):571-4. PubMed ID: 8573536
[TBL] [Abstract][Full Text] [Related]
11. Cerebral metastases from ovarian carcinoma.
LeRoux PD; Berger MS; Elliott JP; Tamimi HK
Cancer; 1991 Apr; 67(8):2194-9. PubMed ID: 2004340
[TBL] [Abstract][Full Text] [Related]
12. Brain Metastases in Patients with Gynecologic Cancers: A Single Institution Experience and Review of the Literature.
Gilani MA; Williams NL; Giordano C; Rosenblum N; Shi W; Anne P; Schilder RJ
Open J Obstet Gynecol; 2016 Aug; 6(9):544-552. PubMed ID: 31552146
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.
Bendell JC; Domchek SM; Burstein HJ; Harris L; Younger J; Kuter I; Bunnell C; Rue M; Gelman R; Winer E
Cancer; 2003 Jun; 97(12):2972-7. PubMed ID: 12784331
[TBL] [Abstract][Full Text] [Related]
14. Profile of gynecologic malignancies reported at a tertiary care center in India over the past decade: comparative evaluation with international data.
Agarwal S; Malhotra KP; Sinha S; Rajaram S
Indian J Cancer; 2012; 49(3):298-302. PubMed ID: 23238148
[TBL] [Abstract][Full Text] [Related]
15. The risk of subsequent malignancies in women with uterine papillary serous or clear cell endometrial cancers.
Hinshaw HD; Smith A; Rungruang B; Kelley JL; Beriwal S; Krivak TC; Sukumvanich P; Olawaiye AB
Int J Gynecol Cancer; 2013 Jul; 23(6):1044-9. PubMed ID: 23748174
[TBL] [Abstract][Full Text] [Related]
16. [Constitutive characteristics and change trend of gynecological malignant tumors in 8009 hospitalized patients in Guangxi Zhuang Autonomous Region].
Huang W; Li L; Yu DQ; Huang YL; Liu Y; Chen XQ; Tang BJ; Xu H; Ma G; Dong LH; Li L; Qiu Y; Bai H; Nong WZ; Li L; Zeng DY; Jiang FY; Lan Y; Ye Y; Tang XZ; Wang DX; Li HZ; Pan YB; Mo AX; Wu XY; Lei ZY; Zhou GP; Liu C; Su QH
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):22-5. PubMed ID: 17331416
[TBL] [Abstract][Full Text] [Related]
17. mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: a critical review.
Husseinzadeh N; Husseinzadeh HD
Gynecol Oncol; 2014 May; 133(2):375-81. PubMed ID: 24556063
[TBL] [Abstract][Full Text] [Related]
18. Brain metastases in patients diagnosed with a solid primary cancer during childhood: experience from a single referral cancer center.
Suki D; Khoury Abdulla R; Ding M; Khatua S; Sawaya R
J Neurosurg Pediatr; 2014 Oct; 14(4):372-85. PubMed ID: 25127097
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain.
Divine LM; Kizer NT; Hagemann AR; Pittman ME; Chen L; Powell MA; Mutch DG; Rader JS; Thaker PH
Gynecol Oncol; 2016 Jul; 142(1):76-82. PubMed ID: 27117923
[TBL] [Abstract][Full Text] [Related]
20. Clinical statistics of gynecologic cancers in Japan.
Yamagami W; Nagase S; Takahashi F; Ino K; Hachisuga T; Aoki D; Katabuchi H
J Gynecol Oncol; 2017 Mar; 28(2):e32. PubMed ID: 28198168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
